EGM
PRTK

Engineers Gate Manager’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Engineers Gate Manager’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-66,833
Closed -$456K – 2077
2021
Q2 		$456K Buy
66,833
+19,761
+42% +$160K 0.03% 881
2021
Q1 		$332K Sell
47,072
-37,382
-44% -$269K 0.02% 1253
2020
Q4 		$529K Buy
+84,454
New +$497K 0.02% 950

Other funds holding PRTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Engineers Gate Manager's PRTK Position: Q3 2021 in Review

Engineers Gate Manager sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2021, closing a stake of 66,833 shares — an estimated $456K sold.

Engineers Gate Manager first reported a position in PRTK in Q4 2020 and held it in 3 quarters. The position peaked at $529K in Q4 2020. 105 funds tracked by Wall St. Rank hold PRTK as of Q3 2021.

  • Engineers Gate Manager reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Engineers Gate Manager sold 66,833 Paratek Pharmaceuticals, Inc. shares in Q3 2021, an estimated $456K.
  • Engineers Gate Manager first reported a position in Paratek Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
  • Engineers Gate Manager's Paratek Pharmaceuticals, Inc. position peaked at $529K in Q4 2020.
  • 105 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2021.

Based on Engineers Gate Manager's 13F filing for Q3 2021, filed 15 Nov 2021.